Dacomitinib, ≥98%

Catalog No. 717371

General Information

Synonyms	PF-00299804
CAS No.	1110813-31-4
M.F.	C₂₄H₂₅ClFN₅O₂
M.W.	469.94

Technical Data

Assay	≥98%
Solubility	DMSO >10 mg/ml (25℃)
Storage	-20℃
Description	Dacomitinib is an orally bioavailable and highly selective inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity.

Reference

Bello CL, et al. Cancer Chemother Pharmacol. 2013 Aug;72(2):379-85
Ramalingam SS, et al. J Clin Oncol. 2012 Sep 20;30(27):3337-44
Kalous O, et al. Mol Cancer Ther. 2012 Sep;11(9):1978-87
Ather F, et al. PLoS One. 2013;8(2):e56112

Size	Price	Quantity	Favorites
10 mg	USD230
50 mg	USD690

Please inquire for non-standard packs and bulk quantities.

Availability: Ships in 1-3 days

For research use only. Not for human use.

> Certificate of Analysis

> MSDS

	(*Required Field)
*Name
*Organization Name
*Country
*Email Address
Phone
Subject	717371, Dacomitinib, ≥98%, 1110813-31-4
*Message
*Code

Dacomitinib, ≥98%

Inquire